TotalMarketCap

Silence Therapeutics

SLNNasdaq United KingdomHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.227 B

$19.74 -0.33%

Close of 6 Nov 2026

As of 6 Nov 2026, Silence Therapeutics (SLN) has a market capitalization of $1.23B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$559.0K

#3506 by revenue

Earnings

-$88.6M

Loss-making

Shares outstanding

141,740,037

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #135OmerosOMER$1.24B
  2. #136Lb PharmaceuticalsLBRX$1.23B
  3. #137Silence TherapeuticsSLN$1.23B
  4. #138MannkindMNKD$1.21B
  5. #139Avalyn PharmaAVLN$1.18B

What if Silence Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$454,306.48

Per share 23,020× higher

Bitcoin $1.53T

$24,581.73

Per share 1,246× higher

Apple $5.02T

$80,699.53

Per share 4,089× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Silence Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.